Literature DB >> 18640800

A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.

Atsushi Ishii1, Goryu Fukuma, Akira Uehara, Tasuku Miyajima, Yoshio Makita, Akiyo Hamachi, Midori Yasukochi, Takahito Inoue, Sawa Yasumoto, Motohiro Okada, Sunao Kaneko, Akihisa Mitsudome, Shinichi Hirose.   

Abstract

BACKGROUND: The underlying genetic abnormalities of rare familial idiopathic epilepsy have been identified, such as mutation in KCNQ2, a K(+) channel gene. Yet, few genetic abnormalities have been reported for commoner epilepsy, i.e., sporadic idiopathic epilepsy, which share a phenotype similar to those of familial epilepsy.
OBJECTIVE: To search for the genetic cause of seizures in a girl with the diagnosis of non-familial benign neonatal convulsions, and define the consequence of the genetic abnormality identified.
METHODS: Genetic abnormality was explored within candidate genes for benign familial neonatal and infantile convulsions, such as KCNQ2, 3, 5, KCNE2, SCN1A and SCN2A. The electrophysiological properties of the channels harboring the identified mutation were examined. Western blotting and immunostaining were employed to characterize the expression and intracellular localization of the mutant channel molecules.
RESULTS: A novel heterozygous mutation (c.910-2delTTC or TTT, Phe304del) of KCNQ2 was identified in the patient. The mutation was de novo verified by parentage analysis. The mutation was associated with impaired functions of KCNQ K(+) channel. The mutant channels were expressed on the cell surface.
CONCLUSION: The mutant Phe304del of KCNQ2 leads to null function of the KCNQ K(+) channel but the mutation does not alter proper channel sorting onto the cell membrane. Our findings indicate that the genes responsible for rare inherited forms of idiopathic epilepsy could be also involved in sporadic forms of idiopathic epilepsy and expand our notion of the involvement of molecular mechanisms in the more common forms of idiopathic epilepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640800     DOI: 10.1016/j.braindev.2008.05.010

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  9 in total

1.  Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies.

Authors:  Rikke S Møller; Line H G Larsen; Katrine M Johannesen; Inga Talvik; Tiina Talvik; Ulvi Vaher; Maria J Miranda; Muhammad Farooq; Jens E K Nielsen; Lene Lavard Svendsen; Ditte B Kjelgaard; Karen M Linnet; Qin Hao; Peter Uldall; Mimoza Frangu; Niels Tommerup; Shahid M Baig; Uzma Abdullah; Alfred P Born; Pia Gellert; Marina Nikanorova; Kern Olofsson; Birgit Jepsen; Dragan Marjanovic; Lana I K Al-Zehhawi; Sofia J Peñalva; Bente Krag-Olsen; Klaus Brusgaard; Helle Hjalgrim; Guido Rubboli; Deb K Pal; Hans A Dahl
Journal:  Mol Syndromol       Date:  2016-08-20

Review 2.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

3.  Site-directed mutagenesis of neonatal convulsions associated KCNQ2 gene and its protein expression.

Authors:  Xi-Hui Zhou; Zhi-Yan Hui; Rui-Ming Shi; Hong-Xia Song; Wei Zhang; Li Liu
Journal:  Transl Pediatr       Date:  2012-10

4.  Genetic testing in the epilepsies--report of the ILAE Genetics Commission.

Authors:  Ruth Ottman; Shinichi Hirose; Satish Jain; Holger Lerche; Iscia Lopes-Cendes; Jeffrey L Noebels; José Serratosa; Federico Zara; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2010-01-19       Impact factor: 5.864

5.  Epi4K: gene discovery in 4,000 genomes.

Authors: 
Journal:  Epilepsia       Date:  2012-05-29       Impact factor: 5.864

6.  The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants.

Authors:  Francesco Miceli; Maria Virginia Soldovieri; Fabio Arturo Iannotti; Vincenzo Barrese; Paolo Ambrosino; Maria Martire; Maria Roberta Cilio; Maurizio Taglialatela
Journal:  Front Pharmacol       Date:  2011-02-01       Impact factor: 5.810

Review 7.  Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential.

Authors:  Jakob Wolfart; Debora Laker
Journal:  Front Physiol       Date:  2015-06-15       Impact factor: 4.566

8.  Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.

Authors:  Yukiko Ihara; Yuko Tomonoh; Masanobu Deshimaru; Bo Zhang; Taku Uchida; Atsushi Ishii; Shinichi Hirose
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

9.  KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients.

Authors:  John J Millichap; Kristen L Park; Tammy Tsuchida; Bruria Ben-Zeev; Lionel Carmant; Robert Flamini; Nishtha Joshi; Paul M Levisohn; Eric Marsh; Srishti Nangia; Vinodh Narayanan; Xilma R Ortiz-Gonzalez; Marc C Patterson; Phillip L Pearl; Brenda Porter; Keri Ramsey; Emily L McGinnis; Maurizio Taglialatela; Molly Tracy; Baouyen Tran; Charu Venkatesan; Sarah Weckhuysen; Edward C Cooper
Journal:  Neurol Genet       Date:  2016-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.